Last modified by ddiadm - 3 years ago

Satdarshan (Paul) Singh Monga, M.D.

Director, Pittsburgh Liver Research Center; Endowed Chair for Experimental Pathology; Vice Chair and Chief of Division of Experimental Pathology

Doctor of Medicine (M.D.), Dayanand Medical College & Hospital, Ludhiana and Punjab University, Chandigarh, India 1993
Postdoctoral Fellowship, Georgetown University & Department of Veterans Affairs Medical Center (DVAMC), Washington, D.C 1997
Postdoctoral Fellowship, Temple University, Fels Cancer Institute, Philadelphia and DVAMC Washington, D.C 1999

For last 12 years, I have been involved with the Interdisciplinary Biomedical Graduate Program (IBGP) as part of the Cellular and Molecular Pathology and Molecular Pharmacology Graduate Programs. I am also the director and PI for the Cellular Approaches to Tissue Engineering & Regeneration program (T32) and training faculty on other grants such as Angiogenesis training program (T32) and on training grant for the Department of Medicine. I am deeply involved in MSTP training and am the course director for their longitudinal clinical clerkship. I have served as course director for various courses offered to the graduate students including “Stem Cells” and “Research Seminars in Regenerative Medicine”. I have trained several pre- and post-doctoral trainees. In addition, I have served as chair and member on thesis committees for various graduate students. I have also been involved with the admissions committee and recruitment committee for the IBGP program as well as for CATER program at the School of Medicine. I consider the education and mentorship mission of our institute, division and training program, of pivotal importance in sustaining and further developing excellent and multidisciplinary research programs that will assure a successful impact on human disease in the long run.

  1. Modeling a Human HCC Subset in Mice Through Co-Expression of Met and Point-Mutant β-Catenin. Tao J, Xu E, Zhao Y, Singh S, Li X, Couchy G, Chen X, Zucman-Rossi J, Chikina M, Monga SP. Hepatology (Baltimore, Md.). 2016; PubMed [journal]PMID: 27097116
  2. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Hansel MC, Davila JC, Vosough M, Gramignoli R, Skvorak KJ, Dorko K, Marongiu F, Blake W, Strom SC. Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.]. 2016; 67:14.13.1-14.13.27. NIHMSID: NIHMS757113 PubMed [journal]PMID: 26828329 PMCID: PMC4795152
  3. Bromodomain and extraterminal (BET) proteins regulate biliary-driven liver regeneration. Ko S, Choi TY, Russell JO, So J, Monga SP, Shin D. Journal of hepatology. 2016; 64(2):316-25. NIHMSID: NIHMS733156 PubMed [journal]PMID: 26505118 PMCID: PMC4718879
  4. Role of β-catenin in development of bile ducts. Cordi S, Godard C, Saandi T, Jacquemin P, Monga SP, Colnot S, Lemaigre FP. Differentiation; research in biological diversity. 2016; 91(1-3):42-9. NIHMSID: NIHMS756779 PubMed [journal]PMID: 26856660 PMCID: PMC4803532
  5. Id2a is required for hepatic outgrowth during liver development in zebrafish. Khaliq M, Choi TY, So J, Shin D. Mechanisms of development. 2015; 138 Pt 3:399-414. NIHMSID: NIHMS695778 PubMed [journal]PMID: 26022495 PMCID: PMC4662648
WordPress Image Lightbox Plugin